Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

PEG‐asparaginase is used as a treatment for Philadelphia‐negative acute lymphoblastic leukemia. In pediatric studies, triglycerides (TGs) were affected more by PEG‐asparaginase than by native L‐asparaginase (10.0% vs. 5.5%). We conducted a retrospective study to determine the safety of re‐challengin...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Nabhani, Ibrahim, Andrews, Claire, Sibai, Jad, Atenafu, Eshetu, Young, Taylor, Chan, Steven M., Gupta, Vikas, Maze, Dawn, Schimmer, Aaron D., Schuh, Andre C., Yee, Karen, Sibai, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928666/
https://www.ncbi.nlm.nih.gov/pubmed/36819167
http://dx.doi.org/10.1002/jha2.607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928666/
https://www.ncbi.nlm.nih.gov/pubmed/36819167
http://dx.doi.org/10.1002/jha2.607

Ejemplares similares